SCHEMBL6826569

SCHEMBL6826569

CC(C)c1c([N+](=O)[O-])ccc2c1c1ccccc1n2C(C)C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.56
MEN1 O00255 3/20 0.56
NPY5R Q15761 4/20 0.47
UTS2R Q9UKP6 1/20 0.38
MAPT P10636 3/20 0.37
CTSB P07858 1/20 0.36
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
BCHE P06276 1/20 0.35
ACHE P22303 1/20 0.35
GAA P10253 1/20 0.35
TDP1 Q9NUW8 3/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
ATM Q13315 1/20 0.35
POLB P06746 1/20 0.35
HTT P42858 1/20 0.35
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6991407 0.93 KMT2A (0.49) KMT2AMEN1NPY5RUTS2RMAPT
SCHEMBL27604176 0.85 KMT2A (0.57) KMT2AMEN1NPY5RUTS2RMAPT
SCHEMBL6826899 0.76 NPY5R (0.48) KMT2AMEN1NPY5RUTS2RMAPT
SCHEMBL1149958 0.71 MEN1 (1.00) KMT2AMEN1NPY5RMAPTATM
SCHEMBL7974800 0.71 MEN1 (0.64) KMT2AMEN1NPY5RMAPTNPC1
SCHEMBL18622105 0.70 ALDH1A1 (0.55) KMT2AMEN1MAPTCTSBTDP1
SCHEMBL6827505 0.70 KMT2A (0.41) KMT2AMEN1NPY5RMAPTCTSB
SCHEMBL6827501 0.69 MEN1 (0.54) KMT2AMEN1NPY5RMAPTNPC1
SCHEMBL6826587 0.69 KMT2A (0.48) KMT2AMEN1NPY5RMAPTNPC1
SCHEMBL27604175 0.68 MEN1 (0.44) KMT2AMEN1NPY5RMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1531527-A Carbazole derivatives and their use as neuropeptide Y5 receptor ligands 2004-09-22 CN disclosed
US-20040067999-A1 Carbazole derivatives and their use as neuropeptide y5 receptor ligands ASTRAZENECA AB (SE) 2004-04-08 US disclosed
EP-1358157-A1 CARBAZOLE DERIVATIVES AND THEIR USE AS NEUROPEPTIDE Y5 RECEPTOR LIGANDS AstraZeneca AB (SE) 2003-11-05 EP disclosed
WO-2002051806-A1 CARBAZOLE DERIVATIVES AND THEIR USE AS NEUROPEPTIDE Y5 RECEPTOR LIGANDS ASTRAZENECA AB (SE) 2002-07-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040067999-A1 Carbazole derivatives and their use as neuropeptide y5 receptor ligands NPY5R, NPY1R, NPY2R KMT2A 3618/4885MEN1 767/4885NPY5R 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.